Nucleotyping

The Nucleotyping system is now entering into the final phase of development. This platform is now automatic, based on monolayer (single nuclei) specimens.

We are now in the process of finalising a platform that can handle routine histological sections. The Nucleotyping system is based on the concept of genome instability in cancer, in line with todays understanding and theories of cancer development. Nucleotyping classifies a tumor based on qualitative and quantitative analyses of DNA and chromatin structure in the tumor cell nuclei using advanced high-resolution digital image analysis.